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doi:10.1016/j.jtcvs.2006.05.019bjective: This study was undertaken to evaluate the frequency, characteristics, and
isk factors of microbiologically documented nosocomial infections after off-pump
oronary artery bypass grafting.
ethods: A prospective cohort study was performed at Henry Dunant Hospital,
thens, Greece. It included all adult patients who underwent coronary artery bypass
rafting with no valve surgery and without the use of cardiopulmonary bypass
uring a period of 3 years. Case patients were those with development of microbi-
logically documented nosocomial infections. Various variables were examined as
ossible risk factors for nosocomial infections.
esults: Twenty-one of 782 studied patients (2.7%) acquired 26 microbiologically
ocumented nosocomial infections after off-pump coronary artery bypass grafting.
ight of 782 studied patients had pneumonia (1.02%), 7 of 782 (0.90%) had
acteremia, 4 of 782 (0.51%) had superficial wound infection at the sternotomy site,
of 782 (0.51%) had urinary tract infection, 2 of 782 (0.26%) had mediastinitis, and
of 782 (0.13%) had pressure sore infection. Twenty-one infections were monomi-
robial, whereas 5 were polymicrobial. All polymicrobial infections were wound
nfections. There was a statistically significant difference in mortality between
atients with and without nosocomial infection (23.8% vs 1.2%, P .001). Clinical
esponse of the infection to the treatment administered was observed in 21 of 26
pisodes (80.8%) in 21 patients. A backward stepwise multivariable logistic regres-
ion model showed that independent risk factors (P  .05) associated with devel-
pment of microbiologically documented nosocomial infection were arterial hyper-
ension, previous vascular surgery, urgent operation, postoperative atrial fibrillation,
umber of inotropes used during and after operation, transfusion of fresh-frozen
lasma during the intensive care unit stay, and intensive care unit stay until
evelopment of infection.
onclusion: Nosocomial infection after off-pump coronary artery bypass grafting is
n uncommon but potentially life-threatening complication. The identification of
ndependent risk factors, including arterial hypertension, associated with develop-
ent of postoperative infection may help in the development of clinical strategies
or the prevention, early diagnosis, and treatment of these infections.
oronary artery bypass grafting (CABG) on a beating heart (off-pump
CABG, or OPCAB) has become common in the last 10 years in an attempt
to decrease the complications associated with the use of extracorporeal
irculation. OPCAB is associated with a significant reduction in inflammatory
esponse, a fact supported by decreased production of interleukin 8, lower postop-
rative concentrations of elastase, and lower postoperative white blood cell, neu-
rophil, and monocyte counts.1,2 A recent meta-analysis of 37 randomized trials that
The Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 3 481
i
w
r
i
s
a
A
n
e
i
l
t
p
s
r
d
c
i
o
P
S
T
H
o
s
c
2
d
w
h
b
d
t
c
a
a
p
A
i
a
h
w
a
o
a
i
n
c
s
D
A
t
h
s
d
a
i
p
w
a
e
d
a
m
s
t
D
P
i
fl
C
p
d
w
fi
t
u
s
S
w
S
D
p
v
a
a
a
o
.
r
S
(
s
a
R
T
o
Cardiopulmonary Support and Physiology Falagas et al
4
CSPncluded 3369 patients showed OPCAB to be associated
ith improved outcome relative to conventional CABG with
espect to hospital stay, intensive care unit (ICU) stay, and
n-hospital and 1-year direct costs. Furthermore, OPCAB
ignificantly decreased respiratory infections, postoperative
trial fibrillation, transfusions, and inotrope requirements.
nother finding of the meta-analysis was that OPCAB did
ot have any impact on 30-day mortality or other postop-
rative complications, such as wound infections, myocardial
nfarction, stroke, renal dysfunction, use of intra-aortic bal-
oon pump, rethoracotomy, and reintervention.3 Postopera-
ive deep wound infection was reported in 0.3% of 7283
atients who underwent OPCAB in 4 study centers with
ignificant beating-heart surgery experience, pneumonia was
eported in 2%, and septicemia was reported in 0.3%.4 We
esigned this prospective study to examine the frequency,
haracteristics, and predisposing factors of all microbiolog-
cally documented nosocomial infections in a large cohort
f patients undergoing OPCAB during a period of 3 years.
atients and Methods
tudy Design and Patient Population
his prospective cohort study was conducted at Henry Dunant
ospital, a tertiary care hospital in Athens, Greece. Approval was
btained from the institutional review board of the hospital. We
tudied all patients who underwent CABG without the use of
ardiopulmonary bypass during a period of 39 months (January
001-March 2004). All patients were admitted to the ICU imme-
iately after cardiac surgery and subsequently transferred to the
ard as appropriate to their medical condition (usually after 24
ours of ICU stay). Case patients were those who acquired micro-
iologically documented nosocomial infection. Patients who un-
erwent valve surgery combined with CABG were excluded from
he study.
Cardiac surgical procedures were performed by a single surgi-
al team with the use of bilateral skeletonized internal thoracic
rteries when indicated, avoiding any procedure on the ascending
orta.5 The sternal closure technique was based on alternative
lacement of figure-of-eight (3 in total) and single sternal wires.
ntibiotic prophylaxis with cefuroxime was given to all patients
ntravenously as a single dose (3 g) at the induction of anesthesia
nd afterward at 750 mg every 8 hours for 2 to 4 days. All patients
ad at least one central venous catheter. Thermodilution catheters
ere used only for high-risk cardiac surgical patients. Hematologic
nd biochemical tests and chest radiographs were performed pre-
peratively and every day during ICU stay and before discharge. In
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
ICU  intensive care unit
OPCAB off-pump CABG
UTI  urinary tract infectionddition, laboratory tests and radiographs were performed as clin- I
82 The Journal of Thoracic and Cardiovascular Surgery ● Septecally indicated. All patients were evaluated daily to detect any
osocomial infection. Bacteriologic examinations of blood, tra-
heal secretions, urine, central venous catheter tips, and wound
wabs were performed as clinically indicated.
ata Collection
ll the microbiologically documented infectious complications
hat occurred in patients who underwent OPCAB during their
ospital stay were identified by prospective active infection control
urveillance. Subsequently, two different case report forms were
esigned. With the first case report form, data were collected for
ll patients undergoing OPCAB who did not acquire nosocomial
nfections. Variables that were considered of interest, including
otential risk factors for development of nosocomial infection,
ere entered into a research database. Especially for patients who
cquired microbiologically documented nosocomial infections, more
laborate data gathering was performed by using a second, more
etailed case report form. The collected data included demographic
nd clinical features. Two blinded reviewers determined the develop-
ent of noninfectious postoperative systemic inflammatory response
yndrome in the first 24 hours after OPCAB, the type of the infection,
he causative pathogens, and the clinical outcome.
efinitions of Infections and Outcomes
neumonia, bacteremia, surgical wound infection, urinary tract
nfection (UTI), and nosocomial infections of other body sites or
uids were defined according to the guidelines published by the
enters for Disease Control and Prevention.6 The primary end
oint of our analysis was the development of microbiologically
ocumented nosocomial infection. The outcome of these infections
as defined as follows: cure was defined as improvement and
nally resolution of presenting symptoms and signs of the infec-
ion by the end of treatment and discharge from the hospital, and
nresponsiveness was defined as persistence or worsening of pre-
enting symptoms or signs of the infection despite treatment.
econdary outcome measured was in-hospital mortality. Patients
ere followed up for 180 days after OPCAB, as per study design.
tatistical Analysis
ata are expressed as mean  SD for continuous variables and as
ercentages for categoric variables. For comparison of continuous
ariables, the Student t test or the Mann-Whitney test for normally
nd nonnormally distributed variables was used. Categoric vari-
bles were compared by 2 or Fisher exact test. Variables associ-
ted with the development of microbiologically documented nos-
comial infection after OPCAB in the bivariable analysis (P 
05) were included in a backward stepwise multivariable logistic
egression model. All statistical analyses were performed with
PSS 11.0 (SPSS Inc, Chicago, Ill) and S-PLUS 6.1 Professional
Insightful Corporation; Seattle, Wash). A finding was considered
tatistically significant if there was a P value lower than 0.05 in the
nalysis of the variables.
esults
wenty-one of 782 studied patients (2.7%) acquired microbi-
logically documented nosocomial infection after OPCAB.
n Table 1, data from the bivariable analysis of predictors of
mber 2006
T
i
V
D
C
C
U
N
N
T
Falagas et al Cardiopulmonary Support and Physiology
CS
PABLE 1. Bivariable analysis of the association of various factors with development of microbiologically documented
nfection after off-pump coronary artery bypass
ariable With infection (n  21) Without infection (n  761) P value
emographic
Age (y, mean  SD) 70.29 11.40 64.74 9.53 .006
Sex (No. female) 6 (28.6%) 101 (13.3) .08
omorbidity (No.)
Hypercholesterolemia 14 (66.7%) 237 (31.1%) .001
Diabetes mellitus 14 (66.7%) 369 (48.5%) .12
Arterial hypertension 18 (85.7%) 264 (34.7%) .001
Chronic obstructive pulmonary disease 10 (47.6%) 100 (13.1%) .001
Anemia (hematocrit 34) on admission 6 (28.6%) 19 (2.5%) .001
Cerebrovascular disease 3 (14.3%) 56 (7.4%) .21
Previous vascular surgery 3 (14.3%) 21 (2.8%) .024
Reoperative on-pump CABG 3 (14.3%) 45 (5.9%) .13
Ejection fraction 42.00 12.21 48.52 11.00 .017
Body surface area (m2, mean  SD) 1.94 0.21 1.86 0.17 .039
reatinine on admission (mean  SD) 1.25 0.45 1.19 0.77 .22
rgent operation (No.) 10 (47.6%) 67 (8.8%) .001
o. of grafts .55
1 (No.) 3 (14.3%) 63 (8.3%)
2 (No.) 5 (23.8%) 278 (36.5%)
3 (No.) 9 (42.9%) 308 (40.5%)
4 (No.) 4 (19.0%) 93 (12.2%)
5 (No.) 0 (0.0%) 16 (2.1%)
6 (No.) 0 (0.0%) 3 (0.4%)
o. of internal thoracic arteries used .19
1 (No.) 5 (23.8%) 103 (13.5%)
2 (No.) 16 (76.2%) 658 (86.5%)
ransfusions of blood products (No.)
RBCs during surgery .001
0 units 9 (42.9%) 692 (90.9%)
1 unit 7 (33.3%) 49 (6.4%)
2 units 4 (19.1%) 14 (1.8%)
3 units 0 (0.0%) 3 (0.4%)
3 units 1 (4.8%) 3 (0.4%)
RBCs during ICU stay .001
0 units 4 (19.1%) 550 (72.3%)
1 unit 3 (12.3%) 115 (15.1%)
2 units 6 (28.6%) 64 (8.4%)
3 units 6 (28.6%) 18 (2.27%)
3 units 2 (9.5%) 14 (1.8%)
FFP during surgery .001
0 units 13 (61.9%) 708 (93.0%)
1 unit 4 (19.1%) 17 (2.2%)
2 units 2 (9.5%) 27 (3.6%)
3 units 1 (4.8%) 3 (0.4%)
3 units 1 (4.8%) 6 (0.8%)
FFP during ICU stay .18
0 units 14 (66.7%) 531 (69.8%)
1 unit 3 (14.3%) 76 (10.0%)
2 units 2 (9.5%) 120 (15.8%)
3 units 0 (0.0%) 13 (1.7%)
3 units 2 (9.5%) 21 (2.8%)
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CSPevelopment of microbiologically documented nosocomial
nfection after OPCAB are presented. Several variables
ere associated with the studied outcome. Table 2 demon-
trates the demographic and clinical data, including comor-
idities, of patients who acquired nosocomial infections.
urthermore, in Table 3 the characteristics of microbiolog-
cally documented nosocomial infections in the same group
f patients are presented. Eight of 782 studied patients
cquired pneumonia (1.02%), 7 of 782 (0.90%) bacteremia,
of 782 (0.51%) superficial wound infection at the sternot-
my site, 4 of 782 (0.51%) UTI, 2 of 782 (0.26%) medias-
initis, and 1 of 782 (0.13%) pressure sore infection. Four
atients had infections at two or more different sites. Spe-
ifically, 1 patient had UTI and mediastinitis, 1 had UTI and
ressure sore infection, 1 had pneumonia and bacteremia,
nd 1 had pneumonia, UTI, and bacteremia. Thus there were
6 episodes of microbiologically documented infections in
1 patients. One patient had bacteremia related to the central
enous catheter, whereas the remaining 4 cases of bactere-
ia were not associated with any other identifiable infected
ite. Seven of 21 patients with nosocomial infection (33.3%)
nderwent direct cardioversion for postoperative atrial fi-
rillation, ventricular tachycardia, or ventricular fibrilla-
ion. Of these 7 patients, 5 acquired pneumonia (5/8, or
2.5% of patients with pneumonia) and 2 acquired bactere-
ia (2/7, or 28.6% of patients with bacteremia).
Twenty-one infections were monomicrobial, whereas 5
ere polymicrobial. All polymicrobial infections were wound
ABLE 1. Continued
ariable
FFP during hospitalization
0 units
1 unit
2 units
3 units
3 units
ostoperative events (No.)
No. of inotropes used
0
1
2
3
3
Intra-aortic balloon pump use (No.)
Postoperative atrial fibrillation (No.)
Stroke after surgery (No.)
echanical ventilation support until development of infection
(h, mean  SD)
CU stay until development of infection (h, mean  SD)
ospital stay until development of infection (d, mean  SD)
BCs, Red blood cells; FFP, fresh-frozen plasma.nfections (pressure sore infection, superficial and deep infec- w
84 The Journal of Thoracic and Cardiovascular Surgery ● Septeions at the sternotomy site). Gram-negative microbes caused
ost of the respiratory tract infections and all the UTIs. En-
erococcus faecalis was the causative pathogen in 6 of 26
pisodes of infection (23.0%), and Staphylococcus aureus was
n 5 of 26 (19.2%). Other gram-positive coccal pathogens were
taphylococcus epidermidis in 3 of 26 (11.5%), Staphylococ-
us hemolyticus in 1 of 26 (3.8%), and Staphylococcus warneri
n 1 of 26 (3.8%). Pseudomonas aeruginosa was the predom-
nant pathogen among gram-negative bacilli and was the caus-
tive organism in 6 of 26 episodes of infection (23.0%),
hereas Klebsiella pneumoniae was causative in 4 of 26
15.4%), Acinetobacter baumannii in 4 of 26 (15.4%), Esch-
richia coli in 2 of 26 (7.7%), Citrobacter koseri in 1 of 26
3.8%), and Proteus mirabilis in 1 of 26 (3.8%). Most caus-
tive pathogens (29/34, or 85.2%) were resistant to cefuroxime
the antibiotic used for perioperative antimicrobial prophy-
axis), whereas 2 of 34 (5.9%) showed intermediate resistance
nd only 3 of 34 (8.8%) were susceptible. Other isolated
rganisms, which were not considered causative pathogens
ccording to the study definitions of infections, were Staphy-
ococcus capitis, Eubacterium lentum, Pseudomonas stutzeri,
nd Candida albicans.
There was a statistically significant difference in mortal-
ty between patients with microbiologically documented
osocomial infection (5/21, or 23.8%) and the rest of the
atients (9/773, or 1.2%, P .001). Clinical response of the
nfection to the administered treatment was observed in 21
f 26 episodes (80.8%) in 21 patients. Unresponsiveness
ith infection (n  21) Without infection (n  761) P value
.62
20 (95.2%) 727 (95.5%)
1 (4.8%) 8 (1.1%)
0 (0.0%) 7 (0.9%)
0 (0.0%) 4 (0.5%)
0 (0.0%) 15 (2.0%)
.001
3 (14.3%) 591 (77.7%)
5 (23.8%) 132 (17.4%)
6 (28.6%) 32 (4.2%)
4 (19.1%) 6 (0.78%)
0 (0.0%) 3 (0.4%)
8 (38.1%) 34 (4.5%) .001
15 (71.4%) 163 (21.4%) .001
1 (4.8%) 6 (0.8%) .17
83.19 88.09 13.55 12.80 .001
107.14 85.87 32.56 20.71 .001
8.57 4.80 8.52 17.01 .06Was observed in 5 of 26 (19.2%) episodes. Three of 4
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Patients whose infections were unresponsive to the admin-
stered therapy had bacteremia. The causative pathogens
ere S aureus and P aeruginosa (cases 17-19 in Table 3);
he fourth patient had a UTI and later mediastinitis from the
ame pathogen (K pneumoniae was isolated from the urine
nd then from pus at the sternotomy site in case 2 in Table 3).
The backward stepwise multivariable logistic regression
odel revealed the independent risk factors associated with
ABLE 2. Continued
haracteristic
Urgency of operation (No.)
Elective 8 (38%)
Urgent 13 (62%)
Very urgent 0 (0%)
Reoperation after OPCAB (No.) 1 (5%)
Intra-aortic balloon pump use
(No.)
8 (38%)
Transfusions during the
operation (No.)
13 (62%)
Use of cell saver (No.) 18 (86%)
fter admission to the ICU
ICU stay (d, mean  SD, range) 7.6 0.7 (0.8-29.8)
Mechanical ventilation support
(d, mean  SD, range)
5.4  8.0 (0.3-26.8)
Use of inotropes (No.) 18 (86%)
Duration of inotropes
(d, mean  SD, range)
2.7  2.4 (0.1-7.9)
Postoperative atrial fibrillation
(No.)
15 (71%)
Deterioration of renal function
(No.)
5 (24%)
Stroke (No.) 2 (10%)
Steroid treatment (No.) 2 (10%)
Systemic inflammatory response
syndrome first 24 h after
operation‡ (No.)
18 (86%)
Tracheostomy (No.) 5 (24%)
atheters
Duration of central venous
catheter (d, mean  SD,
range)
6.0  6.3 (1-24)
Thermodilution catheter (No.) 16 (76%)
Duration of thermodilution
catheter (d, mean  SD,
range)
2.8  2.06 (1-6)
acemaker settlement (No.) 10 (48%)
uration of hospitalization
(d, mean  SD, range)
19.5 10.1 (7-45)
Six patients with diabetes mellitus received oral medication, 4 received
nsulin, and 5 were treated with appropriate diet. †Five patients with signs
nd symptoms of heart failure had ejection fraction 30%, and 8 patients
ad ejection fraction from 30% to 50%. ‡Six patients met 2 criteria for
ystemic inflammatory response syndrome, 9 patients met 3 criteria, and 3
atients met 4 criteria.ABLE 2. Demographic and clinical features of patients
ho underwent off-pump coronary artery bypass and ac-
uired microbiologically documented nosocomial infection
n  21)
haracteristic
emographic
ge (mean  SD, range) 70.3 11.4 (44-85)
ex (No. male) 15 (71%)
uroSCORE on admission to the
operating room (mean 
SD, range)
Standard 10.5 4.7 (3-19)
Logistic (%) 28.3% 26.0% (2.4%-81.1%)
omorbidity
Previous cardiac surgery,
sternotomy (No.)
3 (14%)
Previous percutaneous
transluminal angioplasty
(No.)
2 (10%)
Overweight and obesity (No.) 14 (67%)
Body surface area (m2, mean 
SD, range)
1.9  0.2 (1.4-2.4)
Smoking (No.) 10 (48%)
Diabetes mellitus* (No.) 14 (67%)
Hypercholesterolemia (No.) 14 (67%)
Arterial hypertension (No.) 18 (86%)
Chronic obstructive pulmonary
disease (No.)
10 (48%)
Heart failure† (No.) 13 (62%)
Recent myocardial infarction
(No.)
8 (38%)
Angina pectoris (No.) 15 (71%)
Atrial fibrillation (No.) 1 (5%)
Pulmonary hypertension (No.) 1 (5%)
Peripheral arteriopathy (No.) 9 (43%)
Neurologic disorders (No.) 3 (14%)
Hematologic disorders (No.) 1 (5%)
Malignancy (No.) 17 (34%)
Hepatopathy (No.) 0 (0%)
Chronic renal failure (No.) 6 (29%)
Hemodialysis (No.) 0 (0%)
Previous antibiotic use (No.) 4 (9%)
Previous hospitalization (No.) 14 (67%)
ind of operation (No.)
OPCAB, 1 graft 2 (10%)
OPCAB, 2 grafts 4 (19%)
OPCAB, 3 grafts 8 (38%)
OPCAB, 4 grafts 3 (14%)
OPCAB, 4 grafts; reoperative
OPCAB, 1 graft
1 (5%)
Reoperative OPCAB, 1 graft 1 (5%)
Reoperative OPCAB, 2 grafts 1 (5%)
Reoperative OPCAB, 3 grafts 1 (5%)
Duration of operation
(h, mean  SD, range)
5.0  1.1 (2-7)
Use of bilateral internal thoracic 14 (67%)evelopment of microbiologically documented nosocomial
and Cardiovascular Surgery ● Volume 132, Number 3 485
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CSPnfection to be arterial hypertension, previous vascular sur-
ery, urgent operation, postoperative atrial fibrillation, num-
er of inotropes used during and after operation, transfu-
ABLE 3. Characteristics of microbiologically documented
rtery bypass
atient
o. Site of infection
Infection after
surgery (d)
O
1 Sternal osteomyelitis-mediastinitis 31
2 UTI, mediastinitis 17, 44 Readm
thora
urina
3 Superficial sternotomy site
wound infection
4 Postop
CAB
4 Superficial sternotomy site
wound infection
4 History
prev
5 Superficial sternotomy site
wound infection
14 History
prev
6 Superficial sternotomy site
wound infection
7
7 Pneumonia 1 Postop
card
8 Pneumonia 2 None
9 Pneumonia 4 Postop
card
10 Pneumonia 13 Postop
card
treat
disea
11 Pneumonia 2 Ventric
card
12 Pneumonia 7 Bronch
antit
13 Pneumonia 5 Preope
unkn
14 Pneumonia, bacteremia 6 Postop
card
15 Bacteremia, UTI, pneumonia 18, 19, 28 Postop
16 Catheter-related bacteremia 5 Ventric
card
17 Bacteremia 6 Ventric
curre
18 Bacteremia 5
19 Bacteremia 5 Preope
card
20 UTI, pressure sore infection 20 Paraple
21 UTI 9 Postop
cathions of fresh-frozen plasma during ICU stay, and ICU stay t
86 The Journal of Thoracic and Cardiovascular Surgery ● Septentil development of infection. The odds ratios with 95%
onfidence intervals of the independent predictors of devel-
pment of microbiologically documented nosocomial infec-
comial infection in patients undergoing off-pump coronary
postoperative complications or underlying
conditions
Infection after other
complication (d)
— —
for Dressler syndrome,
esis, placement of permanent
theter
4 (UTI), 31 (deep
wound infection)
e bleeding and reoperative on-pump 4
revious sternotomy (on-pump CABG 20 y
)
—
revious sternotomy (on-pump CABG 9 y
)
—
— —
e atrial fibrillation and direct-current
sion
1
—
e atrial fibrillation and direct-current
sion
0
e atrial fibrillation and direct-current
sion, postoperative corticosteroid
for chronic obstructive pulmonary
10
fibrillation and postoperative direct-current
sion
2
sis, preoperative and postoperative
ulosis treatment
—
e oral antibiotic treatment for fever of
etiology
—
e atrial fibrillation and direct-current
sion
—
e stroke, upper gastrointestinal bleeding 5, 10
fibrillation and postoperative direct-current
sion
1
tachycardia and postoperative direct-
ardioversion
1
— —
e placing of intra-aortic balloon pump for
ic shock
5
postoperative pressure sore —
e urine retention and permanent urinary
lacement
2noso
ther
ission
cent
ry ca
erativ
G
of p
iously
of p
iously
erativ
iover
erativ
iover
erativ
iover
ment
se
ular
iover
iecta
uberc
rativ
own
erativ
iover
erativ
ular
iover
ular
nt c
rativ
iogen
gia,
erativion after OPCAB are presented in Table 4.
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Piscussion
n this prospective cohort study, a 2.7% microbiologically
ocumented infection rate after OPCAB was found. Most
osocomial infections were pneumonia, bacteremia, super-
ABLE 3. Continued
atient
o. Specimens, isolated organisms
1 Tissue culture, S aureus; pus, S aureus, S
warneri, K pneumoniae, A baumannii; blood
culture, E lentum
Wound
stern
musc
treat
2 Urine, K pneumoniae, C albicans; pus,
K pneumoniae, E faecalis, P aeruginosa;
sputum, C albicans
Wound
intrav
3 Pus, S hemolyticus, S epidermidis Intrave
4 Pus, C koseri, E faecalis, P mirabilis; chest
tube drainage, C koseri
Wound
treat
5 Pus, E coli Intrave
6 Tissue culture, S epidermidis Wound
treat
7 Sputum, E coli Intrave
8 Sputum, K pneumoniae Intrave
9 Sputum, A baumannii Intrave
10 Sputum, A baumannii, S aureus; central
venous catheter, S capitis
Trache
11 Sputum, S aureus Intrave
12 Sputum, P aeruginosa, C albicans; central
venous catheter, S epidermidis
Intrave
antitu
13 Sputum, P aeruginosa; central venous
catheter, P aeruginosa
Trache
14 Sputum, S epidermidis; blood cultures, S
epidermidis; pleural fluid, S epidermidis
Intrave
15 Blood cultures, E faecalis; urine, P aeruginosa;
sputum, K pneumoniae, C albicans
Intrave
16 Blood cultures, E faecalis; central venous
catheter, E faecalis, S hemolyticus
Trache
17 Blood cultures, S aureus Intrave
18 Blood cultures, P aeruginosa Intrave
19 Blood cultures, S aureus; central venous
catheter, E faecalis; sputum, P stutzeri, C
albicans
Intrave
20 Urine, E faecalis, C albicans; pus, E faecalis, A
baumannii
Intrave
débri
21 Urine, P aeruginosa Intrave
After surgery for recurrent peripheral emboli.cial wound infection at the sternotomy site, and UTI. Among m
The Journal of Thoracicultiple risk factors that were associated with the development
f postoperative infections in this group of patients in the
ivariable analysis, only 7 were found to be independently
ssociated with development of microbiologically docu-
Management of infection
Infection
outcome
Patient
outcome
idement, chondrectomy, partial
y and sternum rewiring, use of
ps, intravenous antimicrobial
Cure Cure
idement, irrigation with antibiotics,
s antimicrobial treatment
No response Death
antimicrobial treatment Cure Cure
idement, intravenous antimicrobial Cure Cure
antimicrobial treatment Cure Cure
idement, intravenous antimicrobial Cure Cure
antimicrobial treatment Cure Cure
antimicrobial treatment Cure Cure
antimicrobial treatment Cure Death*
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4
CSPThe frequency of microbiologically documented nos-
comial infection in our group of patients is similar to the
requency of major postoperative infection reported in
ome previous studies. For example, Fower and colleagues7
howed that major infection occurred in 11,636 of 331,429
3.5%) patients who underwent CABG (CABG alone or in
ombination with valve surgery, on pump or off pump) from
anuary 1, 2002, to December 31, 2003, according to the
ociety of Thoracic Surgeons National Cardiac Database of
he United States. The frequencies of pneumonia, bactere-
ia, and superficial wound infection in this study are similar
o the results of a previous retrospective analysis that in-
luded 7283 patients who underwent OPCAB.4 In keeping
ith results of other studies, our results do show that mor-
ality among patients who acquired postoperative nosoco-
ial infection was significantly greater than that among
atients without a nosocomial infection.7,8 In addition, cer-
ain nosocomial infections, such as bacteremia and me-
iastinitis from antibiotic-resistant pathogens, are associ-
ted with an increased risk of death. It is noteworthy that a
igh frequency of postoperative nosocomial infection after
onventional CABG has been reported in some studies. For
xample, in a previous case-cohort study, 131 of 605 pa-
ients (21.7%) acquired at least one nosocomial infection
fter cardiac surgery with the use of extracorporeal circu-
ation.8
The multivariable analysis revealed that among multiple
isk factors, arterial hypertension was the most strongly
ssociated with the development of microbiologically doc-
mented nosocomial infection after OPCAB. Bivariable
nalyses of risk factors of development of nosocomial in-
ection after CABG in previous studies have also shown
rterial hypertension to be a significant risk factor for ac-
uiring nosocomial infection, but it was not found to be an
ndependent risk factor in multivariable analyses.7,9 A pos-
ABLE 4. Odds ratios and 95% confidence intervals for
ndependent risk factors associated with development
f microbiologically documented nosocomial infection
fter off-pump coronary artery bypass
ariable Odds ratio 95% CI
rterial hypertension 51.9 6.3-425.5
revious vascular surgery 9.5 1.4-66
rgent operation 8.4 2.0-35.3
ostoperative atrial fibrillation 6.2 1.6-24
umber of inotropes used 4.3 2.0-9.6
ransfusion of fresh-frozen plasma during
ICU stay (per unit)
2.1 1.1-3.9
CU stay* (per hour) 1.015 1.002-1.027
ICU stay was censored at the time of microbiologically documented
osocomial infection after OPCAB for the patients who acquired such an
nfection.ible explanation for this association could be the effect of a
88 The Journal of Thoracic and Cardiovascular Surgery ● Septeong-standing hypertension on arteriolar and arterial sclero-
is, the subsequent reduction of the essential blood supply
and the subsequently intravenous antibiotics possibly given)
o the tissues colonized with nosocomial pathogens. In
ddition, arterial hypertension is accompanied by significant
ncrease in such vascular complications as hemorrhagic or
therothrombotic stroke, peripheral vascular disease, ne-
hrosclerosis, and cardiac arrhythmias, complications that
ay prolong postoperative ICU stay and hospital stay, thus
ncreasing the risk for development of nosocomial infection.
ascular surgery, a consequence of peripheral vascular dis-
ase caused by arteriosclerosis, was also found in our anal-
sis to be an independent risk factor associated with devel-
pment of nosocomial infection.
High preoperative resting systolic blood pressure is a
ignificant predictor for postoperative atrial fibrillation.10
urthermore, previous studies have shown that postopera-
ive atrial fibrillation or a new onset of other type of su-
raventricular tachyarrhythmia in an otherwise stable pa-
ient should prompt a search for postoperative infection.11,12
t is interesting that about 60% of patients with nosocomial
neumonia and 29% of patients with bacteremia in our
tudy underwent direct cardioversion for termination of
ostoperative atrial fibrillation or ventricular arrhythmias
efore the diagnosis of nosocomial infection. There is no
vidence supporting a role of direct cardioversion in the
enesis of nosocomial infections such as pneumonia or
acteremia. On the other hand, several studies have shown
hat the activation of inflammatory processes, as evidenced
y a significant increase of the C-reactive protein plasma
oncentration or white blood cell count, may lead to the
evelopment of postoperative atrial fibrillation. The varia-
ion of these inflammatory indices before and after cardio-
ersion may have prognostic implications regarding sinus
hythm maintenance.13-15
Urgent operation, the use of inotropes after operation,
nd ICU stay were also associated with the development of
ostoperative infection in previous studies.7,16 Infusion of
notropes and prolonged ICU stay may indicate the presence
f severe postoperative complications. In one study, 46% of
ardiac surgical patients with severe sepsis in the ICU had
erious operative complications, and 98% had severe com-
lications.17 Transfusion of fresh-frozen plasma during ICU
tay was also found in our study to be an independent risk
actor associated with nosocomial infection after OPCAB.
he results of previous studies on that subject, however, are
ontradictory. A recent retrospective study that examined
he effect of perioperative transfusion of platelets and fresh-
rozen plasma on infection rates after cardiac surgery
howed that fresh-frozen plasma was not associated with
ostoperative infection.18 To the contrary, another retro-
pective study of 276 patients who underwent CABG and
cquired postoperative infection revealed transfusion of
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Presh-frozen plasma to be a possible risk factor for the
evelopment of bloodstream, respiratory, or deep surgical
ound infections after cardiac surgery.9
With data from the Society of Thoracic Surgeons Na-
ional Cardiac Database of the United States, Fower and
olleagues7 showed that risk factors independently associ-
ted with major infection after CABG were as follows: body
ass index greater than 40 kg/m2, hemodialysis, cardio-
enic shock, age older than 85 years, immunosuppressive
reatment, diabetes mellitus, perfusion time longer than 200
inutes, placement of an intra-aortic balloon pump, and the
resence of three or more anastomoses.7 In a previous study
f our group on postoperative infections after cardiac sur-
ery with the use of extracorporeal circulation, we found
hat history of immunosuppression, transfusion of more
han 5 units of red blood cells during the first postoperative
ay in both the operating room and ICU, and development
f acute renal failure during the first 2 postoperative days
ere independent risk factors for acquisition of postopera-
ive infection in a group of 2122 patients.19 Another mul-
ivariate risk factor analysis in 4474 patients who underwent
ABG demonstrated age, obesity, and diabetes mellitus as
ndependent predictors for surgical site infection. It is in-
eresting that age, obesity, and diabetes mellitus were not
ound to be independently associated with development of
icrobiologically documented nosocomial infection after
PCAB in our group of patients. This constitutes a note-
orthy difference between this study and previous publica-
ions, especially if we take into account the relatively high
ercentage of patients with diabetes in our study and the fact
hat most of them underwent OPCAB with the use of
ilateral internal thoracic arteries.
This study has several limitations. First, because of the
esign of the study, only microbiologically documented
osocomial infections after OPCAB were evaluated. Thus
ther possible postoperative infections that were not micro-
iologically documented were excluded from the analysis.
he reason for this exclusion is the fact that the diagnosis
f nosocomial infection that is not microbiologically doc-
mented in this patient population is sometimes difficult,
ecause clinical and laboratory signs of inflammation and
he systemic inflammatory response syndrome may be caused
ot only by infection but also by tissue injury. Additionally,
he prolonged antibiotic prophylaxis that was given for 2 to
days after operation may, in addition to promoting the
evelopment of antimicrobial resistance, have had a consid-
rable effect on the isolation of microorganisms from blood
pecimens, increasing the probability of false-negative
lood culture results. Second, although we studied a rela-
ively large group of patients, the small number of patients
ith the end point of interest increases the probability of
ype II error, not finding a true association between a
ariable and the outcome of interest. Third, we did not
The Journal of Thoracicnclude a group of patients with postoperative microbiolog-
cally documented nosocomial infection with the use of
xtracorporeal circulation (on-pump CABG) for compari-
on. Although it would be valuable to compare infections
fter OPCAB with infections after on-pump CABG to con-
rast the advantages and disadvantages of the two types of
ABG, we did not have a sufficient number of patients who
nderwent on-pump CABG in our institution to perform a
eaningful statistical comparison. Fourth, the antibiotic
rophylaxis regimen of cefuroxime that was administered
uring the study period is not the currently recommended
egimen according to recent guidelines issued by Medicare
s part of the Surgical Care Infection Project. The fact that
ost of the causative pathogens in our study were resistant
o cefuroxime forced us to change the antibiotic prophylaxis
egimen for high-risk patients undergoing OPCAB in our
ospital. The prolonged antibiotic prophylaxis that was
iven for 2 to 4 days after operation is a major limitation of
ur study. We believe that our results cannot be generalized
o other hospitals, including most US hospitals. It should be
entioned that antibiotic prophylaxis for as long as 72
ours is recommended for cardiothoracic surgical patients
y the American Society of Health-System Pharmacists and
as been adopted in the advisory statement from the Na-
ional Surgical Infection Prevention Project. The authors of
he relevant guidelines, however, suggest that prophylaxis
or 24 hours or less may be appropriate.20,21
In conclusion, nosocomial infection after OPCAB is an
ncommon but potentially life-threatening complication. It
s of interest that arterial hypertension was found to be an
ndependent risk factor for the development of microbio-
ogically documented nosocomial infection after OPCAB.
he identification of independent risk factors associated
ith development of postoperative infection would help
linicians to develop clinical strategies for the prevention,
arly diagnosis, and treatment of these infections, improv-
ng patient outcomes after OPCAB.
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